H.B. Fuller (NYSE:FUL) Reaches New 1-Year Low – Here’s What Happened

H.B. Fuller (NYSE:FUL) reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $60.73 and last traded at $61.45, with a volume of 38676 shares traded. The stock had previously closed at $61.30.

Analyst Upgrades and Downgrades

FUL has been the topic of a number of research reports. JPMorgan Chase & Co. lowered their price target on H.B. Fuller from $70.00 to $60.00 and set an “underweight” rating on the stock in a research report on Friday, January 17th. Citigroup decreased their price objective on H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating on the stock in a report on Friday, January 3rd. Vertical Research lowered H.B. Fuller from a “buy” rating to a “hold” rating in a research note on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on shares of H.B. Fuller from $75.00 to $72.00 and set a “buy” rating on the stock in a research note on Wednesday, January 22nd. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, H.B. Fuller presently has a consensus rating of “Hold” and a consensus price target of $75.60.

H.B. Fuller Price Performance

The company has a current ratio of 1.81, a quick ratio of 1.16 and a debt-to-equity ratio of 1.10. The business’s 50 day moving average price is $67.05 and its two-hundred day moving average price is $75.06. The stock has a market cap of $3.31 billion, a P/E ratio of 26.18, a price-to-earnings-growth ratio of 1.21 and a beta of 1.42.

H.B. Fuller (NYSE:FUL) last posted its quarterly earnings data on Wednesday, January 15th. The specialty chemicals company reported $0.92 earnings per share for the quarter, missing the consensus estimate of $1.00 by ($0.08). H.B. Fuller had a net margin of 3.65% and a return on equity of 12.01%. The firm had revenue of $923.00 million for the quarter, compared to the consensus estimate of $916.84 million. During the same period in the previous year, the firm posted $1.32 earnings per share. The business’s revenue was up 2.2% compared to the same quarter last year. As a group, sell-side analysts expect that H.B. Fuller will post 4.07 earnings per share for the current fiscal year.

H.B. Fuller Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, February 20th. Shareholders of record on Thursday, February 6th will be issued a $0.2225 dividend. The ex-dividend date is Thursday, February 6th. This represents a $0.89 dividend on an annualized basis and a yield of 1.47%. H.B. Fuller’s dividend payout ratio (DPR) is 38.53%.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the business. Geode Capital Management LLC increased its position in H.B. Fuller by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock valued at $99,939,000 after buying an additional 18,734 shares in the last quarter. Lord Abbett & CO. LLC increased its holdings in shares of H.B. Fuller by 79.8% during the third quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock valued at $57,952,000 after acquiring an additional 324,056 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in shares of H.B. Fuller by 17.2% during the fourth quarter. Bank of New York Mellon Corp now owns 554,947 shares of the specialty chemicals company’s stock valued at $37,448,000 after acquiring an additional 81,558 shares in the last quarter. S&CO Inc. raised its position in shares of H.B. Fuller by 0.3% in the 3rd quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company’s stock worth $21,209,000 after purchasing an additional 920 shares during the last quarter. Finally, Amundi boosted its stake in H.B. Fuller by 191.9% in the 4th quarter. Amundi now owns 28,553 shares of the specialty chemicals company’s stock worth $1,804,000 after purchasing an additional 18,771 shares in the last quarter. 95.93% of the stock is owned by hedge funds and other institutional investors.

About H.B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.